Influence of Hepatic Impairment on Pharmacokinetic (PK) and Pharmacodynamic (PD) of Gemigliptin PK and PD After Multiple Oral Doses in Healthy White Volunteers
Clinical trial NCT02004587 · COMPLETED
Trial details
- NCT number
- NCT02004587
- Sponsor
- LG Life Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2014-05-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.